Cannabinoid CB2 receptor agonist activity in the hindpaw incision: Model of postoperative pain

European Journal of Pharmacology

Volumn 527, Issue 1-3, 2005, Pages 172-174

  LaBuda, Christopher J ^a   Koblish, Michael ^a   Little, Patrick J ^a  

^a ADOLOR CORPORATION   (United States)

Author keywords

Cannabinoid; Postoperative pain; Tactile allodynia

Indexed keywords

3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; GW 405833; UNCLASSIFIED DRUG; 1 (2,3 DICHLOROBENZOYL) 5 METHOXY 2 METHYL (2 (MOPHOLIN 4 YL)ETHYL) 1H INDOLE; 1-(2,3-DICHLOROBENZOYL)-5-METHOXY-2-METHYL-(2-(MOPHOLIN-4-YL)ETHYL)-1H-INDOLE; BORNANE DERIVATIVE; CANNABINOID; CANNABINOID 2 RECEPTOR; INDOLE DERIVATIVE; MORPHOLINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ALLODYNIA; ARTICLE; DRUG ACTIVITY; HINDLIMB; MODEL; POSTOPERATIVE PAIN; PRIORITY JOURNAL; ANIMAL; ANIMAL MODEL; DRUG ADMINISTRATION; DRUG ANTAGONISM; DRUG POTENTIATION; FOOT INJURY; MALE; METHODOLOGY; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BORNANES; CANNABINOIDS; DRUG ADMINISTRATION SCHEDULE; FOOT INJURIES; HINDLIMB; INDOLES; MALE; MODELS, ANIMAL; MORPHOLINES; PAIN; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; TIME FACTORS;

EID: 28544440521     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.10.020     Document Type: Article

References (6)

1. T.J. Brennan, E.P. Vandermeulen, and G.F. Gebhart Characterization of a rat model of incisional pain Pain 64 1996 493 501
2. D.J. Buggy, L. Toogood, S. Maric, P. Sharpe, D.G. Lambert, and D.J. Rowbotham Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain Pain 106 2003 169 172
3. 2, a peripheral cannabinoid receptor Proc. Natl. Acad. Sci. U. S. A. 96 1999 14228 14233
4. M.M. Ibrahim, H. Deng, A. Zvonok, D.A. Cockayne, J. Kwan, H.P. Mata, T.W. Vanderah, J. Lai, F. Porreca, A. Makriyannia, and T.P. Malan Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS Proc. Natl. Acad. Sci. U. S. A. 100 2003 10529 10533
5. C.J. LaBuda, and P.J. Little Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat J. Neurosci. Methods 144 2005 175 181
6. K.J. Valenzano, L. Tafesse, G. Lee, J.E. Harrison, J.M. Boulet, S.L. Gottshall, L. Mark, M.S. Pearson, W. Miller, S. Shan, L. Rabadi, Y. Rotshteyn, S.M. Chaffer, P.I. Turchin, D.A. Elsemore, M. Toth, L. Koetzner, and G.T. Whiteside Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy Neuropharmacology 48 2005 658 672